George A. Eldridge, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 46,316 shares at $20.40 ($1.0M) on 2022-12-07, disclosed to the SEC on 2022-12-09.
Open-market sale of $1.0M AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.37 | 7,079 | $137K | 13.5% |
| 2 | $19.37 | 7,079 | $137K | 13.5% |
| 3 | $20.40 | 4,558 | $93K | 9.2% |
| 4 | $20.40 | 4,558 | $93K | 9.2% |
| 5 | $20.12 | 960 | $19K | 1.9% |
| 6 | $20.58 | 20 |
| $412 |
| 0.0% |
| 7 | $24.20 | 11,031 | $267K | 26.3% |
| 8 | $24.20 | 11,031 | $267K | 26.3% |
| Total | $21.89 avg | 46,316 | $1.0M | 100% |
| Filing → |
| AVTE | SELL | 2024-04-03 | $780K | — | Filing → |
| AVTE | SELL | 2024-03-14 | $204K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $736K | — | Filing → |